Biotech

All Articles

Basilea credit ratings $268M BARDA funding for antifungals, anti-biotics

.Basilea Pharmaceutica's job building brand new antifungals has actually received a significant incr...

Capricor offers Europe liberties to late-stage DMD treatment for $35M

.Having presently scooped up the U.S. civil rights to Capricor Therapeutics' late-stage Duchenne mus...

FDA junks adcomm for Applied's unusual disease medicine

.After pushing the choice meeting for Applied Therapeutics' metabolic problem medicine govorestat, t...

Novo inks $600M NanoVation package to analyze genetic drugs ex-liver

.Novo Nordisk is proceeding its push in to hereditary medicines, accepting to compensate NanoVation ...

Innovent hyperlinks cytokine to intestines cancer feedbacks

.Innovent Biologics has helped make the scenario that its own gate inhibitor-cytokine blend healthy ...

Merck, Daiichi ADC attacks objective in phase 3 lung cancer cells research

.A period 3 test of Daiichi Sankyo and Merck &amp Co.'s HER3-directed antibody-drug conjugate (ADC) ...

Rakovina deepens AI focus along with collab to pick cancer cells targets

.Five months after Rakovina Rehabs pivoted towards artificial intelligence, the cancer-focused biote...

Ascendis' dwarfism medicine hits in stage 3, threatens BioMarin

.Ascendis Pharma has actually become a possible threat to BioMarin's Voxzogo, mentioning period 3 de...

Despite ph. 3 miss, Alkeus finds pathway in advance for eye ailment asset

.Though Alkeus Pharmaceuticals' oral eye health condition possession stopped working to dramatically...

Kairos goes public along with $6M IPO to money tests of cancer drug

.Along with a trio of biotechs reaching the Nasdaq on Friday, it was very easy to miss a smaller-sca...